Recombinant vaccines against bluetongue virus (Q38167166)

30 August 2017

Recombinant vaccines against bluetongue virus (English)

1 reference

30 August 2017

0 references

Alejandro Marín-López

object named as

Alejandro Marín-López

6

0 references

Javier Castillo-Olivares

object named as

Javier Castillo-Olivares

2

0 references

Javier Ortego

object named as

Javier Ortego

4

0 references

author name string

Eva Calvo-Pinilla

1

1 reference

PubMed ID

24287057

30 August 2017

Tamara Jabbar

3

1 reference

PubMed ID

24287057

30 August 2017

Francisco de la Poza

5

1 reference

30 August 2017

25 November 2013

1 reference

30 August 2017

1 reference

30 August 2017

182

1 reference

30 August 2017

78-86

1 reference

Tumor regression induced by intratumor therapy with a disabled infectious single cycle (DISC) herpes simplex virus (HSV) vector, DISC/HSV/murine granulocyte-macrophage colony-stimulating factor, correlates with antigen-specific adaptive immunity.

30 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Antigen specificity of the ovine cytotoxic T lymphocyte response to bluetongue virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Response of the regional lymph node to bluetongue virus infection in calves.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

A European field strain of bluetongue virus derived from two parental vaccine strains by genome segment reassortment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Development of reverse genetics systems for bluetongue virus: recovery of infectious virus from synthetic RNA transcripts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Multiserotype protection elicited by a combinatorial prime-boost vaccination strategy against bluetongue virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Experimental oral infection of bluetongue virus serotype 8 in type I interferon receptor-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Establishment of a Bluetongue Virus Infection Model in Mice that Are Deficient in the Alpha/Beta Interferon Receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Heterologous prime boost vaccination with DNA and recombinant modified vaccinia virus Ankara protects IFNAR(-/-) mice against lethal bluetongue infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

A modified vaccinia Ankara virus (MVA) vaccine expressing African horse sickness virus (AHSV) VP2 protects against AHSV challenge in an IFNAR -/- mouse model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Rapid generation of replication-deficient monovalent and multivalent vaccines for bluetongue virus: protection against virulent virus challenge in cattle and sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Cross-neutralization of genetic reassortants of bluetongue virus serotypes 20 and 21.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Clinical signs and pathology shown by British sheep and cattle infected with bluetongue virus serotype 8 derived from the 2006 outbreak in northern Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Particulate vaccines: on the quest for optimal delivery and immune response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Use of real-time RT-PCR as a rapid molecular approach for differentiation of field and vaccine strains of bluetongue virus serotypes 2 and 9.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Epizootic hemorrhagic disease virus infection of type I interferon receptor deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Attenuated poxvirus vectors MVA and NYVAC as promising vaccine candidates against HIV/AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Active circulation of bluetongue vaccine virus serotype-2 among unvaccinated cattle in central Italy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Immunization of knock-out α/β interferon receptor mice against lethal bluetongue infection with a BoHV-4-based vector expressing BTV-8 VP2 antigen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Comparative safety study of three inactivated BTV-8 vaccines in sheep and cattle under field conditions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Expression of the non-structural protein NS1 of bluetongue virus in bacteria and yeast: identification of two antigenic sites at the amino terminus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

3-D reconstruction of bluetongue virus tubules using cryoelectron microscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Isolation of a capsid protein of bluetongue virus that induces a protective immune response in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Protection of IFNAR (-/-) mice against bluetongue virus serotype 8, by heterologous (DNA/rMVA) and homologous (rMVA/rMVA) vaccination, expressing outer-capsid protein VP2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

The ovine cytotoxic T lymphocyte responses to bluetongue virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Role of neutralising antibody in passive immunity to bluetongue infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

The non-structural proteins of bluetongue virus are a dominant source of cytotoxic T cell peptide determinants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

IMVAMUNE: modified vaccinia Ankara strain as an attenuated smallpox vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Antibody responses and protective immunity to recombinant vaccinia virus-expressed bluetongue virus antigens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

An equine herpesvirus type 1 (EHV-1) expressing VP2 and VP5 of serotype 8 bluetongue virus (BTV-8) induces protection in a murine infection model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Identification and differentiation of the twenty six bluetongue virus serotypes by RT-PCR amplification of the serotype-specific genome segment 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Expression of the outer capsid proteins VP2 and VP5 of bluetongue virus in Saccharomyces cerevisiae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Generation of replication-defective virus-based vaccines that confer full protection in sheep against virulent bluetongue virus challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Assignment of the genome segments of bluetongue virus type 1 to the proteins which they encode.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Analysis of the roles of bluetongue virus outer capsid proteins VP2 and VP5 in determination of virus serotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

The genome segments of bluetongue virus: the proteins they encode and the relationship between different isolates by cross-hybridazation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Prokaryotic expression of truncated VP7 of bluetongue virus (BTV) and reactivity of the purified recombinant protein with all BTV type-specific sera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Recombinant capripoxviruses expressing proteins of bluetongue virus: evaluation of immune responses and protection in small ruminants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

T cell responses to bluetongue virus are directed against multiple and identical CD4+ and CD8+ T cell epitopes from the VP7 core protein in mouse and sheep.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Protection of mice by equine herpesvirus type 1 based experimental vaccine against lethal Venezuelan equine encephalitis virus infection in the absence of neutralizing antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Effects of protein aggregates: an immunologic perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Bluetongue virus genetics and genome structure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Bluetongue virus proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Protective efficacy of virus-like particles for bluetongue disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

An equine herpesvirus 1 (EHV-1) vectored H1 vaccine protects against challenge with swine-origin influenza virus H1N1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Vaccines against bluetongue in Europe.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Bluetongue virus serotype 8 virus-like particles protect sheep against virulent virus infection as a single or multi-serotype cocktail immunogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

A method for rapid production of heteromultimeric protein complexes in plants: assembly of protective bluetongue virus-like particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Bluetongue viruses based on modified-live vaccine serotype 6 with exchanged outer shell proteins confer full protection in sheep against virulent BTV8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Viraemia and clinical disease in Dorset Poll sheep following vaccination with live attenuated bluetongue virus vaccines serotypes 16 and 4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

Recombinant virus vaccine for bluetongue disease in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2013.11.013

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIRUSRES.2013.11.013

1 reference

30 August 2017

1 reference

PubMed ID

24287057